Published in Eur J Nucl Med Mol Imaging on June 01, 2007
The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med (2000) 13.25
Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed (2004) 6.94
Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med (2003) 2.33
ATP flux through creatine kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci U S A (2005) 2.17
Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium. Circulation (2006) 1.84
Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol (2003) 1.80
Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol (1998) 1.64
Cardiovascular magnetic resonance imaging: current and emerging applications. J Am Coll Cardiol (2004) 1.56
Non-invasive magnetic-resonance detection of creatine depletion in non-viable infarcted myocardium. Lancet (1998) 1.25
Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent. Circulation (2005) 1.23
Seeing within: molecular imaging of the cardiovascular system. Circ Res (2004) 1.22
Measuring human cardiac tissue sodium concentrations using surface coils, adiabatic excitation, and twisted projection imaging with minimal T2 losses. J Magn Reson Imaging (2005) 1.08
Molecular magnetic resonance imaging of atrial clots in a swine model. Circulation (2005) 1.07
Assessment of myocardial viability by intracellular 23Na magnetic resonance imaging. Circulation (2004) 0.90
The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med (1999) 5.21
Magnetic resonance imaging in coronary artery disease. Circulation (1995) 2.57
No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. J Am Coll Cardiol (2001) 2.31
Concern Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J (2001) 2.26
Quantification of pulmonary and systemic blood flow by magnetic resonance velocity mapping in the assessment of atrial-level shunts. Int J Card Imaging (1996) 2.04
Left ventricular hypertrophy screening using a hand-held ultrasound device. Eur Heart J (2002) 1.95
Refinements in stress echocardiographic techniques improve inter-institutional agreement in interpretation of dobutamine stress echocardiograms. Eur Heart J (2002) 1.87
MR imaging of marrow changes adjacent to end plates in degenerative lumbar disk disease. AJR Am J Roentgenol (1987) 1.73
Comparison of echocardiographic methods with magnetic resonance imaging for assessment of right ventricular function in children. Am J Cardiol (1995) 1.69
Left ventricular measurements with cine and spin-echo MR imaging: a study of reproducibility with variance component analysis. Radiology (1993) 1.63
Non-compaction cardiomyopathy-echocardiographic diagnosis. Eur J Echocardiogr (2002) 1.59
Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping. Circulation (1993) 1.55
Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome. Am J Cardiol (1998) 1.55
Doppler tissue velocity sampling improves diagnostic accuracy during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction. Eur Heart J (2000) 1.55
Effect of intramyocardial bone marrow cell injection on left ventricular dyssynchrony and global strain. Heart (2008) 1.55
COPD and cancer mortality: the influence of statins. Thorax (2009) 1.53
No increased risk of valvular heart disease in adult poststreptococcal reactive arthritis. Arthritis Rheum (2009) 1.53
Prevalence of (a)symptomatic peripheral arterial disease; the additional value of ankle-brachial index on cardiovascular risk stratification. Eur J Vasc Endovasc Surg (2009) 1.51
Assessing right ventricular function: the role of echocardiography and complementary technologies. Heart (2006) 1.50
Right ventricular hypertrophy and diastolic dysfunction in arterial switch patients without pulmonary artery stenosis. Heart (2007) 1.50
Variability of splanchnic blood flow measurements using MR velocity mapping under fasting and post-prandial conditions--comparison with echo-Doppler. J Hepatol (1997) 1.50
Improved MR flow mapping in coronary artery bypass grafts during adenosine-induced stress. Radiology (2001) 1.47
Dobutamine-atropine stress myocardial perfusion SPECT imaging in the diagnosis of graft stenosis after coronary artery bypass grafting. J Nucl Cardiol (1999) 1.44
Perioperative blood glucose monitoring and control in major vascular surgery patients. Eur J Vasc Endovasc Surg (2009) 1.43
Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass. J Clin Endocrinol Metab (2001) 1.43
Cardiac CT and CT coronary angiography: technology and application. Heart (2008) 1.42
Biophysical properties of the normal-sized aorta in patients with Marfan syndrome: evaluation with MR flow mapping. Radiology (2001) 1.42
Agreement and disagreement between "metabolic viability" and "contractile reserve" in akinetic myocardium. J Nucl Cardiol (1999) 1.40
[Intramyocardial injection of autologous bone-marrow stem cells in a 74-year-old man with untreatable angina pectoris and demonstrated myocardial ischaemia]. Ned Tijdschr Geneeskd (2006) 1.40
[Screening of asymptomatic individuals for coronary disease using CT-calcium measurement in the coronary arteries]. Ned Tijdschr Geneeskd (2006) 1.40
Reprinted article "A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery". Eur J Vasc Endovasc Surg (2011) 1.40
Comparison between manual and semiautomated analysis of left ventricular volume parameters from short-axis MR images. J Comput Assist Tomogr (1997) 1.39
[Prophylactic perioperative beta-blockade reduces cardiac morbidity and mortality following non-cardiac surgery in patients at risk]. Ned Tijdschr Geneeskd (2004) 1.39
Development of an MRI-compatible catheter for pacing the heart: initial in vitro and in vivo results. J Magn Reson Imaging (1997) 1.39
[Right-ventricular dysfunction and the pulmonary vascular obstruction index: predictable variables of the clinical course over 3 months in patients with acute lung emboli]. Ned Tijdschr Geneeskd (2006) 1.39
Automated measurement of volume flow in the ascending aorta using MR velocity maps: evaluation of inter- and intraobserver variability in healthy volunteers. J Comput Assist Tomogr (1998) 1.37
Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab (2005) 1.35
A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart (2003) 1.35
Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA (2001) 1.34
Value of fast gradient echo magnetic resonance angiography as an adjunct to coronary arteriography in detecting and confirming the course of clinically significant coronary artery anomalies. Am J Cardiol (1997) 1.33
Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up. Neurology (2010) 1.33
Postoperative pulmonary flow dynamics after Fontan surgery: assessment with nuclear magnetic resonance velocity mapping. J Am Coll Cardiol (1993) 1.32
Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography? Eur Heart J (2003) 1.32
Functional and metabolic evaluation of the athlete's heart by magnetic resonance imaging and dobutamine stress magnetic resonance spectroscopy. Circulation (1998) 1.31
EANM/ESC guidelines for radionuclide imaging of cardiac function. Eur J Nucl Med Mol Imaging (2008) 1.29
Quantification of right ventricular function with magnetic resonance imaging in children with normal hearts and with congenital heart disease. Am Heart J (1995) 1.28
Left ventricular function: correlation of quantitative gated SPECT and MR imaging over a wide range of values. Radiology (2000) 1.28
Magnetic resonance measurement of velocity and flow: technique, validation, and cardiovascular applications. Am Heart J (1993) 1.27
Comparison of ultrafast dipyridamole magnetic resonance imaging with dipyridamole SestaMIBI SPECT for detection of perfusion abnormalities in patients with one-vessel coronary artery disease: assessment by quantitative model fitting. Magn Reson Med (1996) 1.26
Radiofrequency catheter ablation of ventricular tachycardia guided by intracardiac echocardiography. Eur J Echocardiogr (2004) 1.25
Comparison of gated single-photon emission computed tomography with magnetic resonance imaging for evaluation of left ventricular function in ischemic cardiomyopathy. Am J Cardiol (2000) 1.25
Right ventricular diastolic function in children with pulmonary regurgitation after repair of tetralogy of Fallot: volumetric evaluation by magnetic resonance velocity mapping. J Am Coll Cardiol (1996) 1.23
Detection and quantification of dysfunctional myocardium by magnetic resonance imaging. A new three-dimensional method for quantitative wall-thickening analysis. Circulation (1997) 1.22
Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation (1999) 1.19
Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: A single-center experience. Circulation (1999) 1.17
Intracardiac pseudotumor caused by mitral annular calcification. Eur J Echocardiogr (2005) 1.17
Increased uptake of iodine-123-BMIPP in chronic ischemic heart disease: comparison with fluorine-18-FDG SPECT. J Nucl Med (1998) 1.17
Clinical application of CT coronary angiography: state of the art. Heart Lung Circ (2010) 1.17
Magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease. Quantitative wall motion analysis using a modification of the centerline method. Circulation (1994) 1.17
Arrhythmogenic right ventricular dysplasia: MRI findings. Herz (2000) 1.17
Adenocarcinoma arising within a tailgut cyst: clinicopathological description and follow up of an unusual case. J Clin Pathol (1999) 1.17
Prognostic and clinical correlates of angiographically diffuse non-obstructive coronary lesions. Heart (2003) 1.15
Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: implications of time course of recovery on diagnostic accuracy. J Am Coll Cardiol (1998) 1.15
Imaging in cardiac resynchronisation therapy. Neth Heart J (2008) 1.15
Cardiac first-pass and myocardial perfusion in normal subjects assessed by sub-second Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr (1991) 1.15
Aortic stiffness is associated with cardiac function and cerebral small vessel disease in patients with type 1 diabetes mellitus: assessment by magnetic resonance imaging. Eur Radiol (2009) 1.14
Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions. Int J Endocrinol (2012) 1.14
Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg (2006) 1.13
Noninvasive evaluation of aortocoronary bypass grafts with magnetic resonance flow mapping. Am J Cardiol (1995) 1.12
Anatomical and functional imaging techniques: basically similar or fundamentally different? Neth Heart J (2007) 1.11
Differences in plaque composition and distribution in stable coronary artery disease versus acute coronary syndromes; non-invasive evaluation with multi-slice computed tomography. Acute Card Care (2007) 1.11
Artifacts in ECG-synchronized MDCT coronary angiography. AJR Am J Roentgenol (2007) 1.10
Quantitation of global and regional left ventricular function by cine magnetic resonance imaging during dobutamine stress in normal human subjects. Eur Heart J (1993) 1.10
Acute, subacute, and chronic myocardial infarction: quantitative analysis of gadolinium-enhanced MR images. Radiology (1991) 1.10
Quantitative analysis of cardiovascular MR images. Int J Card Imaging (1997) 1.08
Gadolinium contrast-enhanced three-dimensional MRA of peripheral arteries with multiple bolus injection: scan optimization in vitro and in vivo. Int J Card Imaging (1999) 1.08
Biventricular systolic function and mass studied with MR imaging in children with pulmonary regurgitation after repair for tetralogy of Fallot. Radiology (1996) 1.08
Stress echocardiography for risk stratification of diabetic patients with known or suspected coronary artery disease. Diabetes Care (2001) 1.05
Abdominal aortic aneurysm screening using a hand-held ultrasound device. "A pilot study". Eur J Vasc Endovasc Surg (2001) 1.05
Diagnosis and management of anomalous origin of the right coronary artery from the left coronary sinus. Int J Card Imaging (1999) 1.04
Chemotherapy for testicular cancer induces acute alterations in diastolic heart function. Br J Cancer (2013) 1.04
Comparison of magnetic resonance imaging studies with enzymatic indexes of myocardial necrosis for quantification of myocardial infarct size. Am J Cardiol (1993) 1.04
Reproducibility of human cardiac 31P-NMR spectroscopy. NMR Biomed (1996) 1.02
Evaluation of left ventricular function and volumes in patients with ischaemic cardiomyopathy: gated single-photon emission computed tomography versus two-dimensional echocardiography. Eur J Nucl Med (2001) 1.01
Treatment of mesenteric desmoid tumours with the anti-oestrogenic agent toremifene: case histories and an overview of the literature. Eur J Gastroenterol Hepatol (1999) 1.01
Assessment of myocardial viability in chronic ischemic heart disease: current status. Q J Nucl Med Mol Imaging (2005) 1.01
Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis. Ann Rheum Dis (2007) 1.01
A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg (2004) 1.00
The influence of aging on the prognostic value of the revised cardiac risk index for postoperative cardiac complications in vascular surgery patients. Eur J Vasc Endovasc Surg (2007) 0.99
Impaired glucose regulation, elevated glycated haemoglobin and cardiac ischaemic events in vascular surgery patients. Diabet Med (2008) 0.99
Usefulness of ultrafast magnetic resonance imaging in healed myocardial infarction. Am J Cardiol (1992) 0.98
Clinical applications of cardiac magnetic resonance imaging after repair of tetralogy of Fallot. Pediatr Cardiol (2000) 0.98
Echocardiographic evaluation of cardiac dyssynchrony for predicting a favourable response to cardiac resynchronisation therapy. Heart (2004) 0.98